PRGO (perrigo.com) Company Projected Revenue

Official company branding of Perrigo Company PLC (PRGO)

Perrigo Company plc leverages a global network of over-the-counter products and infant nutrition, creating deep retailer dependency on its supplies. Its status as a trusted B2B partner guarantees the high quality of essential medicines, while capacity expansion optimizes costs and stabilizes profits. The company's future sales trajectory confirms these points, with the parameter value reaching 4.09.

PRGO - Perrigo Company plc Company Expected Sales Volume over the range 07/04/2022 - 11/15/2026

Financial and market metric breakdowns for Perrigo Company (PRGO)

- stock value and consensus price forecast:
- business market valuation indicators:
Basic company analysis:perrigo.com
Signature product of Perrigo Company PLC

To identify fundamental sector leaders, the analyst evaluates cash flow dynamics, capturing real-time market revenue expectations. Using GURU.Markets tools, the projected sales volume reveals a gap between the share price and the actual earnings of Perrigo Company plc (PRGO), confirming the effectiveness of their strategy to expand affordable generics and pediatric nutrition during periods of inflationary pressure.

Competitor analysis

Projected Sales Volume HLN|KVUE (Kenvue Inc) - Company Future Revenue|Verona Pharma Corp - Company Future Sales Volume|Company Projected Revenue Volume MENS (Jyong Biotech Ltd)|ligand.com - Projected Sales Volume|amneal.com (AMRX) - Company Future Sales Volume|ALVO (Alvotech SA) - Company Future Sales Volume|Company Sales Forecast Liquidia Technologies LQDA|GLPG (Galapagos N.V.) - Projected Sales Volume|ANIP: Company Future Revenue|Company Projected Revenue Afrezza (MNKD)|Projected Sales Volume amphastar.com (AMPH)|Projected Sales Volume PCRX (pacira.com)|Company Future Revenue SPRY|Theravance Biopharma Inc - Projected Sales Volume|Company Future Sales Aquestive Therapeutics AQST|SCPH: Projected Sales Volume|Company Future Sales Volume Tectonic Therapeutic, Inc.|TNXP (tonixpharma.com) - Projected Sales Volume|SXTC (China SXT Pharmaceuticals, Inc.) - Company Projected Revenue Volume|Company Projected Revenue eupraxiapharma.com (EPRX)|Company Projected Revenue Volume BHST|Company Projected Revenue eXoZymes EXOZ|Company Future Revenue ORMP|ENTX - Company Projected Revenue|HYFT: Company Projected Revenue|ABVC BioPharma, Inc (ABVC) - Company Projected Revenue|Cumberland Pharma - Company Future Revenue|QNTM (Quantum BioPharma Corp) - Projected Sales Volume|FibroGen, Inc. - Company Expected Revenue|Projected Sales Volume TELO|Company Future Sales Rani Therapeutics Holdings, Inc.|Company Projected Revenue Synergy CHC Corp. SNYR|Projected Sales Volume rallybio.com RLYB|Lexaria Bioscience Corp. - Projected Sales Volume|PULM: Company Projected Revenue|PTHL (ftzy.com.cn) - Company Future Sales Volume|APM: Company Projected Revenue Volume|LYRA (Lyra Therapeutics Inc) - Projected Sales Volume|Company Revenue Forecast IBO (Impact BioMedical)|Company Future Sales Volume TNFA (TNF Pharmaceuticals)|Projected Sales Volume cbdMD Corp (YCBD)|Projected Sales Volume PRFX (PainReform)|Company Future Sales Auris Medical (CYTO)|LIPO - Company Projected Revenue|Optinose (OPTN) - Company Future Sales Volume|Pieris (PIRS) - Company Projected Revenue|Company Expected Revenue PROC (Procaps Group S.A.)|Company Future Sales Volume PTPI|QLI: Company Future Revenue|Company Projected Revenue acelyrin.com (SLRN)|TFFP (TFF Pharma) - Company Future Revenue